Dyrk1a has been implicated in several DS phenotypes and craniofacial abnormalities [50,66,32,67] and in the last decade has become one of the top candidate gene in DS for therapeutic intervention [72,39]. This evidence concerns the gene DYRK1A and Dravet syndrome.